A patient in their early seventies with a history of smoking and emphysema presented with intermittent coughing. The patient was diagnosed with small cell lung cancer, extensive stage in 2019. From March 2021 to August 2021, the patient received six cycles of chemotherapy with carboplatin AUC 5 mg/ml/min, day 1, combined with etoposide 100 mg/m2, day 1–3, i.v. drip, every 3 weeks. In November 2021, imaging assessment showed cancer progression. From November 2021 to February 2022, the patient received four cycles of chemotherapy with albumin-bound paclitaxel 260 mg/m2, day 1, i.v. drip, every 3 weeks. In June 2022, imaging showed cancer progression. In June 2022, the patient initiated two cycles of anlotinib 12 mg, day 1–14, orally, every 3 weeks. In July 2022, during the